Freya Ophthalmics
PrivateLast Round
Series A
Oct 29, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Freya Ophthalmics is a biotech company that develops a drug-eluting contact lens platform for the treatment of ocular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Freya Ophthalmics Comparables
Compare Freya Ophthalmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OcuMedic, Inc. | 93% | |
| MediPrint Ophthalmics | 88% | |
| Mati Therapeutics | 80% | |
Freya Ophthalmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 29, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2025
$14.25M round completed.
Freya Ophthalmics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Freya Ophthalmics's valuation, stock price, and market status.